Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025
Areteia Therapeutics, Inc. (“Areteia”), a clinical-stage biotechnology company developing novel inflammation and immunology therapies, with an initial focus on severe eosinophilic asthma, today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025 at 1:30 p.m. PT in San Francisco, CA.
A copy of the presentation will be posted on the Company’s website following the presentation.
Event:
J.P. Morgan Healthcare Conference
Venue:
Alphemy Capital appoints Barry Schachter as Head of Portfolio Risk Management
Alphemy Capital S.A. (“Alphemy Capital”), a leading digital asset and blockchain investment manager, has appointed Barry Schachter as Head of Portfolio Risk Management.
Schachter formally joined the firm in January 2025 after nine months as its Risk Management Advisor, where he worked closely with the investment team in developing new tools and analytics to enhance Alphemy Capital’s existing risk management framework.
“UNESCO For The People”: Khaled El-Enany Unveils His Campaign Slogan for the Position of Director-General of UNESCO
This press release is issued by the Egyptian Campaign for the Post of Director-General of UNESCO.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114334927/en/
(Photo: Business Wire)